AnorTech Inc

As of June 30, 2026, AnorTech Inc carries a market capitalization of 26.21M, placing it among publicly traded companies globally. Its enterprise value stands at 24.82M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, AnorTech Inc has 201.60M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, AnorTech Inc maintains a current ratio of 29.20, meaning it holds 29.2x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, AnorTech Inc posted a negative return on equity (ROE) of -28.96, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -28.72, reflecting losses generated across the asset base.

As of the close on October 22, 2026, AnorTech Inc's stock has gained approximately 130.77% over the past 52 weeks. The 50-day moving average sits at 0.12, while the 200-day moving average is 0.09.

Over the twelve months ended June 30, 2026, AnorTech Inc generated - - in revenue and converted that into -997,043.00 in net income, yielding earnings per share of -0.01. EBITDA reached -1.04M, while operating income came in at -1.04M.

These figures are as of June 30, 2026. Total book value stands at 4.61M, with working capital of 1.39M providing operational flexibility.

AnorTech Inc produced -814,928.00 in operating cash flow over the twelve months ended June 30, 2026.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -3.45: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow.

As of June 30, 2026, AnorTech Inc has an Altman Z-Score of 290.37, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.